The price to buy certain infused biosimilars can be three times higher than reimbursement, and the problem is growing.
Biosimilar Pipeline Analysis Market BURLINGAME, CA, UNITED STATES, February 6, 2025 /EINPresswire / -- The global Biosimilar Pip ...
Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...
4Q Earnings: $410 million (loss of $3.4 billion 4Q24) ...
Biohaven, acquired by Pfizer in 2022, allegedly took doctors to high-end restaurants and paid speaker honoraria for preferential prescriptions.
Pfizer posted Q4 revenue of $17.76 billion, up 22% YoY, with strong sales from Paxlovid, Vyndaqel, and Eliquis. The company reaffirmed its 2025 revenue outlook.
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended 3 biosimilars and new indications for reference biologics, moving them closer to final European ...
US biotech major Amgen =announced that it has reached resolution of its patent infringement litigation related to South Korea ...